This inventor holds 2 USPTO granted patents and 5 published patent applications and 2 EPO patents. Top assignees: Cancer Research Technology Limited, Glaxosmithkline Intellectual Property (No.2) Limited, Glaxosmithkline Intellectual Property Development Limited. Active years: 2018-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 268 
1 out of 95 
1 out of 242 
Years Active: 2018-2021
Title: Innovations and Contributions of Karen Anderson Evans
Introduction
Karen Anderson Evans is a notable inventor based in Collegeville, PA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target various diseases. With a total of two patents to her name, her work has the potential to impact the treatment of serious health conditions.
Latest Patents
One of her latest patents is titled "Substituted pyridines as inhibitors of DNMT1." This invention focuses on substituted pyridine derivatives that serve as selective inhibitors of DNMT1. These compounds can be beneficial in treating cancer, pre-cancerous syndromes, and various blood disorders, including sickle cell disease and beta thalassemia. The invention also encompasses pharmaceutical compositions that include these compounds and methods for inhibiting DNMT1 activity.
Another significant patent is "Substituted bridged urea analogs as sirtuin modulators." This invention relates to novel substituted bridged urea analog compounds that act as Sirtuin Modulators. These compounds are useful for increasing the lifespan of cells and can aid in treating a range of diseases, including those related to aging, diabetes, obesity, and neurodegenerative disorders. The invention also includes processes for making and using these compounds in combination with other therapeutic agents.
Career Highlights
Throughout her career, Karen has worked with prominent companies, including GlaxoSmithKline Intellectual Property Limited and GlaxoSmithKline Intellectual Property Development Limited. Her experience in these organizations has allowed her to contribute to significant advancements in pharmaceutical research and development.
Collaborations
Karen has collaborated with notable individuals in her field, including William Henry Miller and James Lamond Ellis. These partnerships have likely enhanced her research and innovation efforts, leading to the successful development of her patented compounds.
Conclusion
Karen Anderson Evans is a distinguished inventor whose work in pharmaceuticals has the potential to transform treatment options for various diseases. Her innovative patents reflect her commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile